Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody f...
Leadership
Arnon Rosenthal Ph.D.Founder
Co-Founder, CEO & Director
Neil Berkley M.B.A., M.S.
CFO & Chief Business Officer
Katie Hogan
Senior Director of Corporate Communication & Investor Relations
Danielle Pasqualone J.D., Ph.D.
General Counsel
Clare Hunt M.B.A.
Chief People & Places Officer
Kristina Cutter M.P.H.
Chief Development Officer
Hua Long DABT, Ph.D.
Senior VP & Head of Research
Eric Brown Ph.D.
Director of Antibody Discovery & Protein Engineering
